Ocata Therapeutics Inc fka OCAT

[rocky301]

UPDATE: Casey Eye Involvement With Both Trials plus Recruitment info

I had several e-mail exchanges with Maureen Toomey , Study Coordinator for Casey Eye. They will be in on the dryAMD trial also. Below is a quick snapshot followed by e-mail responses.

[B]Stargardt Trial[/B]

1) recruitment has not started yet
2) ACT needs to travel to Casey for training meeting
3) Mid June contemplated for training meeting
4) After meeting and after stem cells received, recruitment can begin


[B]DRY AMD[/B]

1) ACT asked them to be a site a couple weeks ago
2) In the process of IRB approval and negotiating contract
3) Probably a couple months before recruitment begins

____________________________________________________________________________ On 05/26/2011 10:16 AM, Maureen Toomey wrote:

Dear Rocky,

Thank you for your email. About a couple of weeks ago, Advanced Cell Technology asked us to be a site in the Dry AMD study. We are currently in the process of obtaining institutional approval to begin recruitment and negotiating the contract. I expect it will be another couple months or so before we are ready to begin recruiting patients.
Hope this helps.
Maureen

Maureen Toomey, BS, CCRP
Study Coordinator
Casey Eye Institute
3375 SW Terwilliger Blvd.
Portland, OR 97239
Ph: 503-494-3795
Fax: [phone]

Rocky,
We have not yet started to recruit patients for the Stargardt’s study. ACT still needs to travel to our site for a training meeting. This will probably occur in the middle of June. Shortly after the site visit and after we receive the stem cells, we should be ready to recruit patients.
Thanks,

Maureen